Holen Sie sich die Stockscreener-App
2.90
0.00%
0.00
Handel nachbörslich:
3.17
0.27
+9.31%
Schlusskurs vom Vortag:
$2.90
Offen:
$2.8893
24-Stunden-Volumen:
22,669
Relative Volume:
0.46
Marktkapitalisierung:
$4.32M
Einnahmen:
$59.11M
Nettoeinkommen (Verlust:
$-33.38M
KGV:
-0.0162
EPS:
-178.995
Netto-Cashflow:
$-26.04M
1W Leistung:
-28.92%
1M Leistung:
-47.56%
6M Leistung:
-75.68%
1J Leistung:
-92.84%
1-Tages-Spanne:
$2.80
$3.0851
1-Wochen-Bereich:
$2.80
$4.10
52-Wochen-Spanne:
$2.5211
$61.00
Dna X Inc Stock (SONM) Company Profile
Firmenname
Dna X Inc
Sektor
Branche
Telefon
650-378-8100
Adresse
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
2.90 | 4.32M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corporation
|
372.74 | 2.84T | 305.45B | 119.26B | 77.41B | 15.98 |
ORCL
Oracle Corp
|
147.09 | 443.89B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
154.78 | 384.68B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
392.99 | 104.82B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
415.62 | 82.85B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-31 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-09 | Hochstufung | National Securities | Neutral → Buy |
| 2019-06-10 | Eingeleitet | National Securities | Neutral |
| 2019-06-04 | Eingeleitet | Lake Street | Buy |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Dna X Inc Aktie (SONM) Neueste Nachrichten
How DNA's Double Helix Structure Was Discovered - Britannica
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
SONM Earnings History & Surprises | EPS & Revenue Results | DNA X INC (NASDAQ:SONM) - ChartMill
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
DNA Holdings takes 19.99% stake in DNA X, Inc. (SONM) with board rights - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis - Nature
1 Main Capital exits Sonim Technologies (SONM) with 0.0% ownership - Stock Titan
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan
GPT-5 lab runs 36,000 experiments, cuts protein costs 40% - Stock Titan
Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today - Yahoo Finance
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru
Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors - Yahoo Finance
Best Tech Penny Stocks Right Now • Updated Daily - Benzinga
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - IT Business Net
Five reasons to go rugged in public safety: Sonim Technologies on building phones for fireground realties - International Fire & Safety Journal
Sonim Technologies rebrands as DNA X following asset sale to NEXA - Investing.com Nigeria
Sonim Technologies Rebrands as DNA X, Shifts Strategy - TipRanks
DNA X Signs Asset Purchase Agreement Amendment and Terminates Streeterville Notes - TradingView
Sonim sells assets, rebrands as DNA X running digital asset platform - stocktitan.net
EPS Watch: Is Sonim Technologies Inc exposed to currency risksMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn
Market Wrap: Is Sonim Technologies Inc affected by consumer sentimentWeekly Stock Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sonim Technologies : NEXA Completes Acquisition of Sonim - marketscreener.com
Sonim Technologies : News Release - marketscreener.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Sonim Technologies (SONM) Projected to Post Earnings on Friday - Defense World
Volatility Watch: Should value investors consider Sonim Technologies IncWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Sentiment Review: What is the Moat Score of Sonim Technologies IncJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Portfolio Recap: What are the risks of holding Sonim Technologies IncJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Whats the fair value of Sonim Technologies Inc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Resistance Check: Will Sonim Technologies Inc benefit from seasonalityWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products - Business Wire
Quarterly Trades: Is Sonim Technologies Inc affected by consumer sentimentWeekly Trend Recap & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Finanzdaten der Dna X Inc-Aktie (SONM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):